结构方程模型评估成人疫苗犹豫量表对孕期推荐疫苗的适用性
研究于2021年12月至2022年4月对美国917名产后成人进行横断面全国在线调查,用结构方程模型评估成人疫苗犹豫量表(aVHS)测量孕期推荐疫苗犹豫的结构。结果显示双因子模型拟合可接受,缺乏疫苗信心与流感及新冠疫苗接受度显著相关,感知疫苗风险与Tdap及流感疫苗接受度显著相关;aVHS评分较高者接种推荐产前疫苗的可能性较低。
要点
- aVHS双因子模型拟合可接受:RMSEA 0.098、CFI 0.983、TLI 0.978、SRMR 0.040。
- 缺乏疫苗信心与流感疫苗接受度β=-0.41、新冠疫苗接受度β=-0.64显著相关。
- 感知疫苗风险与Tdap疫苗接受度β=-0.57、流感疫苗接受度β=-0.25显著相关。
核心结论
- aVHS对孕期疫苗犹豫提供可接受的测量,但测量妊娠特异性担忧的量表可能为这一独特人群提供更贴合的测量。
研究设计与样本
- 2021年12月至2022年4月开展的横断面全国在线调查,纳入917名过去六个月内分娩的18-49岁美国产后成人。
- 疫苗犹豫采用既往在成人一般人群中验证的10条目成人疫苗犹豫量表(aVHS)测量,评分范围10至50分,分数越高表示疫苗犹豫越强。
- 使用加权最小二乘均值与方差调整(WLSMV)估计量的结构方程模型(SEM)评估aVHS结构拟合,并通过aVHS评分与自我报告的孕期推荐疫苗接种情况的相关性评估结构效度。
主要发现
- SEM显示数据对双因子模型拟合可接受:RMSEA 0.098、CFI 0.983、TLI 0.978、SRMR 0.040;两因子为缺乏疫苗信心和感知疫苗风险。
- 缺乏疫苗信心与流感疫苗接受度显著相关(β = -0.41,p < 0.001),与新冠疫苗接受度显著相关(β = -0.64,p < 0.001)。
- 感知疫苗风险与Tdap疫苗接受度显著相关(β = -0.57,p < 0.001),与流感疫苗接受度显著相关(β = -0.25,p < 0.001)。
- aVHS评分较高的孕期人群接种推荐产前疫苗的可能性较低。
关键数值与推荐
- aVHS评分范围10至50分,分数越高表示疫苗犹豫越强。
- 双因子模型拟合指标:RMSEA 0.098、CFI 0.983、TLI 0.978、SRMR 0.040。
- 缺乏疫苗信心与流感疫苗接受度β = -0.41(p < 0.001),与新冠疫苗接受度β = -0.64(p < 0.001)。
- 感知疫苗风险与Tdap疫苗接受度β = -0.57(p < 0.001),与流感疫苗接受度β = -0.25(p < 0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Acceptance of recommended vaccines is lower among pregnant people compared to non-pregnant adults, yet no tool has specifically measured prenatal vaccine hesitancy. We evaluated the performance of an existing adult Vaccine Hesitancy Scale (aVHS) in measuring vaccine hesitancy toward routinely recommended prenatal vaccines. METHODS: Between December 2021 and April 2022, we conducted a cross-sectional national online survey with 917 US postpartum adults 18-49 years old who had given birth in the past six months. Vaccine hesitancy was measured using the aVHS, a 10-item scale previously validated among the adult general population. Scores range from 10 to 50, with higher scores indicating greater vaccine hesitancy. Structural equation modeling (SEM) with weighted least squares means and variances adjusted (WLSMV) estimator was used to assess the fit of the aVHS structure. Construct validity was assessed by examining the correlation between the aVHS score and the self-reported receipt of recommended prenatal vaccines. RESULTS: SEM indicated acceptable fit (RMSEA: 0.098; CFI: 0.983; TLI: 0.978; SRMR: 0.040) of the data to the two-factor model: (1) lack of vaccine confidence, and (2) perceived vaccine risks. For the paths from the two factors to the vaccine acceptance, lack of vaccine confidence was significantly correlated with influenza vaccine acceptance (β = -0.41, p < 0.001) and COVID-19 vaccine acceptance (β = -0.64, p < 0.001), while perceived vaccine risk was significantly linked with Tdap vaccine acceptance (β = -0.57, p < 0.001) and influenza vaccine acceptance (β = -0.25, p < 0.001). Additionally, pregnant people with higher aVHS scores were less likely to receive recommended prenatal vaccines. DISCUSSION: Although the aVHS offered acceptable measurement of prenatal vaccine hesitancy, a scale that measures pregnancy-specific concerns may offer more tailored measurement for this unique population.
引用
- Nuzhath T, Yang Y, Couture MC, et al. Structural equation modeling to evaluate the adult vaccine hesitancy scale for vaccines recommended during pregnancy. Vaccine. 2024. PMID: 39705797. doi:10.1016/j.vaccine.2024.126568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。